- Home
- TLSI vs BRY Comparison
TLSI vs BRY Comparison
Compare TLSI & BRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- BRY
- Stock Information
- Founded
- TLSI 2010
- BRY 1909
- Country
- TLSI United States
- BRY United States
- Employees
- TLSI N/A
- BRY N/A
- Industry
- TLSI Medical Specialities
- BRY Oil & Gas Production
- Sector
- TLSI Health Care
- BRY Energy
- Exchange
- TLSI Nasdaq
- BRY Nasdaq
- Market Cap
- TLSI 244.3M
- BRY 249.1M
- IPO Year
- TLSI N/A
- BRY N/A
- Fundamental
- Price
- TLSI $4.70
- BRY $3.29
- Analyst Decision
- TLSI Strong Buy
- BRY Hold
- Analyst Count
- TLSI 4
- BRY 2
- Target Price
- TLSI $11.13
- BRY $4.00
- AVG Volume (30 Days)
- TLSI 131.5K
- BRY 821.1K
- Earning Date
- TLSI 11-13-2025
- BRY 11-05-2025
- Dividend Yield
- TLSI N/A
- BRY 3.60%
- EPS Growth
- TLSI N/A
- BRY N/A
- EPS
- TLSI N/A
- BRY 0.07
- Revenue
- TLSI $35,990,000.00
- BRY $701,914,000.00
- Revenue This Year
- TLSI $56.71
- BRY N/A
- Revenue Next Year
- TLSI $52.25
- BRY N/A
- P/E Ratio
- TLSI N/A
- BRY $51.11
- Revenue Growth
- TLSI 45.50
- BRY N/A
- 52 Week Low
- TLSI $3.42
- BRY $2.11
- 52 Week High
- TLSI $5.88
- BRY $5.90
- Technical
- Relative Strength Index (RSI)
- TLSI 45.51
- BRY 38.18
- Support Level
- TLSI $4.87
- BRY $3.32
- Resistance Level
- TLSI $5.18
- BRY $3.41
- Average True Range (ATR)
- TLSI 0.23
- BRY 0.09
- MACD
- TLSI -0.01
- BRY -0.02
- Stochastic Oscillator
- TLSI 44.74
- BRY 3.64
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About BRY Berry Corporation (bry)
Berry Corp (bry) is a western United States independent upstream energy company with a focus on the conventional, long-lived oil reserves in the San Joaquin basin of California. Its operating segments includes Exploration and Production (E&P) and Well Servicing and Abandonment. The company generates maximum revenue from the Exploration and Production (E&P) segment.